| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.101 | 11.844 | 9.446 | 5.851 | 5.476 | 4.747 | 2.790 | 3.137 | 4.044 | 3.919 |
| Total Income - EUR | 7.101 | 11.844 | 9.446 | 5.851 | 5.476 | 4.747 | 2.790 | 3.138 | 4.044 | 3.919 |
| Total Expenses - EUR | 11.446 | 12.388 | 9.888 | 8.179 | 6.018 | 1.026 | 1.790 | 1.099 | 3.105 | 5.852 |
| Gross Profit/Loss - EUR | -4.345 | -544 | -442 | -2.327 | -542 | 3.722 | 1.000 | 2.038 | 939 | -1.934 |
| Net Profit/Loss - EUR | -4.559 | -781 | -537 | -2.386 | -676 | 3.618 | 992 | 1.944 | 679 | -1.934 |
| Employees | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Natural Bio Activ Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 46 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 4.495 | 5.573 | 4.901 | 3.882 | 3.825 | 6.042 | 4.835 | 5.528 | 6.055 | 4.357 |
| Inventories | 4.147 | 5.285 | 4.270 | 3.662 | 2.932 | 5.165 | 4.518 | 5.053 | 4.692 | 1.717 |
| Receivables | 0 | 0 | 0 | 64 | 86 | 101 | 99 | 0 | 131 | 130 |
| Cash | 348 | 287 | 632 | 156 | 807 | 776 | 218 | 475 | 1.232 | 2.510 |
| Shareholders Funds | -4.559 | -5.294 | -5.697 | -7.979 | -8.500 | -4.719 | -3.623 | -1.690 | -1.005 | -2.933 |
| Social Capital | 0 | 0 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 9.146 | 10.867 | 10.598 | 11.860 | 12.325 | 10.761 | 8.458 | 7.218 | 7.060 | 7.290 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4711 - 4711" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Natural Bio Activ Pharma Srl